Abby L. Nerlinger, MD

Social determinants of health screening in pediatric healthcare settings; Current Opinion in Pediatrics; (2023).

Advocacy in Pediatric Academia: Charting a Path Forward; Pediatric Clinics of North America; (2023).

Academic Careers in Advocacy: Aligning Institutional Values Through Use of an Advocacy Portfolio; Pediatrics; (2022).

Faculty Support for Advocacy Is Key to Training the Next Generation of Pediatrician-Advocates; Hospital Pediatrics; (2022).

Evaluating the Efficacy of Medical-Legal Partnerships that Address Social Determinants of Health.; Progress in community health partnerships : research, education, and action; (2021).

The Advocacy Portfolio: A Standardized Tool for Documenting Physician Advocacy; Academic Medicine; (2018).

Biomonitoring hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-Specific IgG; Annals of Occupational Hygiene; (2012).

Socioeconomic predictors of weight loss after laparoscopic Roux-Y gastric bypass; Surgical Endoscopy; (2009).

Effects of the polycyclic aromatic hydrocarbon heterocycles, carbazole and dibenzothiophene, on in vivo and in vitro CYP1A activity and polycyclic aromatic hydrocarbon-derived embryonic deformities; Environmental Toxicology and Chemistry; (2005).